By Mill Chart
Last update: Nov 9, 2023
DEXCOM INC (NASDAQ:DXCM) has caught the eye of our stock screener as an affordable growth stock. NASDAQ:DXCM is displaying robust growth metrics and also excels in terms of profitability, solvency, and liquidity. Additionally, it appears to be reasonably priced. Let's delve into the details.
To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. NASDAQ:DXCM has achieved a 9 out of 10:
To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NASDAQ:DXCM has achieved a 5 out of 10:
Every stock is evaluated by ChartMill, receiving a Health Rating on a scale of 0 to 10. This assessment considers different health aspects, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:DXCM has achieved a 6 out of 10:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:DXCM, the assigned 8 is noteworthy for profitability:
More Affordable Growth stocks can be found in our Affordable Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of DXCM
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
NASDAQ:DXCM (2/23/2024, 7:00:01 PM)After market: 116.26 0 (0%)
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
The FDA warns of risks associated with using smartwatches or smart rings claiming to measure blood glucose levels without piercing the skin.
Which S&P500 stocks are moving before the opening bell on Thursday?
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.
Tiger Global Management's latest 13F filing reveals exits from Alibaba and other stocks, while taking new stakes in Dexcom and Broadcom.
Expectations are high for companies making blood sugar monitors and business automation software.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready for round two!
Companies in the healthcare industry tend to generate returns in a wide range of market environments.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.